3BOTTINGER E P,BITZER M. TGF-beta signaling in renal disease[J].Journal of the American Society of Nephrology,2002,(10):2600-2610.doi:10.1097/01.ASN.0000033611.79556.AE.
4TOSSIDOU I,STARKER G,KRUGER J. PKC-alpha modulates TGF-beta signaling and impairs podocyte survival[J].Cellular Physiology and Biochemistry,2009,(5/6):627-634.doi:10.1159/000257518.
7JAVELAUD D,MAUVIEL A. Transforming growth factor-betas:Smad signaling and roles in physiopathology[J].Pathologie Biologie(Pairs),2004,(01):50-54.
8Ng Y Y,Hou C C,Wang W. Blockade of NFKappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney[J].Kidney International Supplement,2005,(94):S83-S91.
9LAN H Y. Smad7 as a therapeutic agent for chronic kidney diseases[J].Frontiers in Bioscience,2008.4984-4992.
8Radeke HH, Meier B,Topley N, et al. Interleukin 1 - alpha and tumor necrosis factor - alpha induce oxygen radical production in mesangial ceils [ J ]. Kidney Int, 1990, 37 ( 2 ) :767 - 775.
9Mantovani A, Bussolino F, Introna M. Cytokinc regulation of endothelial cell function: from molecular level to the bedside [ J ]. Immunol Today, 1997,18 ( 5 ) :231 - 40.
10Chen S,Hong SW, Iglesias - delacruz MC, et al. The key roleof transforming growth factor - beta system in the pathogen - esis of diabetic nephropathy[ J ]. Ren Fail ,2001,23 (3/4) :471.
